We ought to think about how long patents should be.
I'm of the belief that we need more oversight of the FDA.
The overarching question we have to ask is: Does the FDA care about drug prices?
When I first heard about the EpiPen price increases going up 500 percent, I was like anybody else, outraged.
That was a reaction to the contaminated steroid injections that happened at the company--what, up in Massachusetts or so...
If you reform it such that you speed up the process of getting the patent and getting the approval, then they have a lon...
I like the idea of maybe starting a generic application process before it expires.
It's kind of hard to get bureaucrats out of Washington.
They just don't understand why it costs 500 percent more, particularly when the ingredients are quite inexpensive.
Maybe we should expedite things when there's only one person making something and the price goes up at an alarming pace.
Right. Some of the published material also said that Adrenaclick was not therapeutically equivalent to EpiPen.